Clearday, Inc. (CLRD)
USD 0.07
(0.0%)
USD 0.07
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2022 | 44.86 Million USD | -9.13% |
| 2021 | 49.37 Million USD | 10.45% |
| 2020 | 44.7 Million USD | 8068.07% |
| 2019 | -561 Thousand USD | 90.01% |
| 2018 | -5.61 Million USD | -83.77% |
| 2017 | -3.05 Million USD | 70.76% |
| 2016 | -10.45 Million USD | -39.94% |
| 2015 | -7.46 Million USD | 99.4% |
| 2014 | -1.23 Billion USD | 83.4% |
| 2013 | -7.45 Billion USD | -105.26% |
| 2012 | -3.63 Billion USD | 41.05% |
| 2011 | -6.16 Billion USD | -1.58% |
| 2010 | -6.06 Billion USD | 41.16% |
| 2009 | -10.31 Billion USD | -37.74% |
| 2008 | -7.48 Billion USD | -92.32% |
| 2007 | -3.89 Billion USD | 28.85% |
| 2006 | -5.47 Billion USD | 57.85% |
| 2005 | -12.98 Billion USD | -10.15% |
| 2004 | -11.78 Billion USD | -65.68% |
| 2003 | -7.11 Billion USD | 55.72% |
| 2002 | -16.06 Billion USD | -9.65% |
| 2001 | -14.65 Billion USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q2 | 22.61 Million USD | 6.24% |
| 2023 Q1 | 21.29 Million USD | -52.55% |
| 2023 Q3 | 24.32 Million USD | 7.53% |
| 2022 Q4 | 44.86 Million USD | 47.6% |
| 2022 Q2 | 88.6 Million USD | 73.79% |
| 2022 Q3 | 30.39 Million USD | -65.69% |
| 2022 Q1 | 50.98 Million USD | 3.26% |
| 2022 FY | 44.86 Million USD | -9.13% |
| 2021 Q1 | -823 Thousand USD | -101.84% |
| 2021 FY | 49.37 Million USD | 10.45% |
| 2021 Q2 | 126 Thousand USD | 115.31% |
| 2021 Q3 | 51.43 Million USD | 40718.35% |
| 2021 Q4 | 49.37 Million USD | -4.0% |
| 2020 Q4 | 44.7 Million USD | 102.54% |
| 2020 Q1 | 2.9 Million USD | 100.52% |
| 2020 Q2 | -2.38 Billion USD | -82232.04% |
| 2020 Q3 | -1.76 Billion USD | 26.03% |
| 2020 FY | 44.7 Million USD | 8068.07% |
| 2019 Q1 | -2.99 Billion USD | 46.69% |
| 2019 Q3 | 22 Million USD | 101.09% |
| 2019 Q2 | -2.02 Billion USD | 32.43% |
| 2019 FY | -561 Thousand USD | 90.01% |
| 2019 Q4 | -561 Million USD | -2650.0% |
| 2018 Q4 | -5.61 Billion USD | 25.97% |
| 2018 Q3 | -7.58 Billion USD | -627.33% |
| 2018 Q2 | -1.04 Billion USD | 64.27% |
| 2018 Q1 | -2.91 Billion USD | 4.48% |
| 2018 FY | -5.61 Million USD | -83.77% |
| 2017 Q1 | -8.41 Billion USD | 19.5% |
| 2017 Q4 | -3.05 Billion USD | 0.0% |
| 2017 FY | -3.05 Million USD | 70.76% |
| 2017 Q2 | -6.46 Billion USD | 23.2% |
| 2016 Q4 | -10.45 Billion USD | -207.86% |
| 2016 FY | -10.45 Million USD | -39.94% |
| 2016 Q3 | -3.39 Billion USD | 0.64% |
| 2016 Q2 | -3.41 Billion USD | 38.7% |
| 2016 Q1 | -5.57 Billion USD | 25.37% |
| 2015 FY | -7.46 Million USD | 99.4% |
| 2015 Q4 | -7.46 Billion USD | -541.67% |
| 2015 Q3 | -1.16 Billion USD | 57.75% |
| 2015 Q2 | -2.75 Billion USD | 47.6% |
| 2015 Q1 | -5.25 Billion USD | -324.72% |
| 2014 Q1 | -7.76 Billion USD | -4.14% |
| 2014 FY | -1.23 Billion USD | 83.4% |
| 2014 Q4 | -1.23 Billion USD | -26.58% |
| 2014 Q3 | -978 Million USD | 72.87% |
| 2014 Q2 | -3.6 Billion USD | 53.59% |
| 2013 Q2 | -1.61 Billion USD | 2.6% |
| 2013 Q3 | -10.26 Billion USD | -536.52% |
| 2013 FY | -7.45 Billion USD | -105.26% |
| 2013 Q4 | -7.45 Billion USD | 27.35% |
| 2013 Q1 | -1.65 Billion USD | 54.43% |
| 2012 Q4 | -3.63 Billion USD | -45.24% |
| 2012 FY | -3.63 Billion USD | 41.05% |
| 2012 Q1 | -9.53 Billion USD | -54.58% |
| 2012 Q2 | -5.37 Billion USD | 43.65% |
| 2012 Q3 | -2.5 Billion USD | 53.41% |
| 2011 Q1 | -16.11 Billion USD | -165.48% |
| 2011 Q4 | -6.16 Billion USD | 36.11% |
| 2011 Q2 | -12.7 Billion USD | 21.17% |
| 2011 Q3 | -9.65 Billion USD | 24.02% |
| 2011 FY | -6.16 Billion USD | -1.58% |
| 2010 FY | -6.06 Billion USD | 41.16% |
| 2010 Q1 | -8.49 Billion USD | 17.69% |
| 2010 Q2 | -5.49 Billion USD | 35.31% |
| 2010 Q4 | -6.06 Billion USD | 26.36% |
| 2010 Q3 | -8.24 Billion USD | -50.05% |
| 2009 Q3 | -12.66 Billion USD | 3.82% |
| 2009 Q1 | -5.01 Billion USD | -141.34% |
| 2009 Q2 | -13.16 Billion USD | -162.73% |
| 2009 FY | -10.31 Billion USD | -37.74% |
| 2009 Q4 | -10.31 Billion USD | 18.52% |
| 2008 Q3 | -10.63 Billion USD | 17.67% |
| 2008 Q2 | -12.92 Billion USD | -10.81% |
| 2008 Q1 | -11.66 Billion USD | -199.49% |
| 2008 Q4 | 12.12 Billion USD | 213.92% |
| 2008 FY | -7.48 Billion USD | -92.32% |
| 2007 FY | -3.89 Billion USD | 28.85% |
| 2007 Q1 | -3.14 Billion USD | 42.63% |
| 2007 Q4 | -3.89 Billion USD | -59.13% |
| 2007 Q3 | -2.44 Billion USD | 15.53% |
| 2007 Q2 | -2.89 Billion USD | 7.74% |
| 2006 FY | -5.47 Billion USD | 57.85% |
| 2006 Q4 | -5.47 Billion USD | 0.0% |
| 2006 Q2 | -7.07 Billion USD | 23.69% |
| 2006 Q1 | -9.26 Billion USD | 28.64% |
| 2005 Q4 | -12.98 Billion USD | 12.6% |
| 2005 FY | -12.98 Billion USD | -10.15% |
| 2005 Q1 | -6.76 Billion USD | 42.65% |
| 2005 Q2 | -6.69 Billion USD | 0.93% |
| 2005 Q3 | -14.85 Billion USD | -121.85% |
| 2004 Q3 | -6.37 Billion USD | 42.07% |
| 2004 Q2 | -10.99 Billion USD | -322.06% |
| 2004 Q1 | -2.6 Billion USD | 63.37% |
| 2004 Q4 | -11.78 Billion USD | -85.0% |
| 2004 FY | -11.78 Billion USD | -65.68% |
| 2003 FY | -7.11 Billion USD | 55.72% |
| 2003 Q2 | -13.49 Billion USD | -33.7% |
| 2003 Q4 | -7.11 Billion USD | 31.08% |
| 2003 Q3 | -10.32 Billion USD | 23.51% |
| 2003 Q1 | -10.09 Billion USD | 37.18% |
| 2002 Q1 | -20.62 Billion USD | -40.75% |
| 2002 Q2 | -14.63 Billion USD | 29.03% |
| 2002 Q3 | -7.53 Billion USD | 48.51% |
| 2002 Q4 | -16.06 Billion USD | -113.19% |
| 2002 FY | -16.06 Billion USD | -9.65% |
| 2001 Q3 | -19.11 Billion USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2001 FY | -14.65 Billion USD | 0.0% |
| 2001 Q4 | -14.65 Billion USD | 23.35% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| The Amacore Group, Inc. | -469.62 Thousand USD | 9653.942% |
| Arem Pacific Corporation | 181.02 Thousand USD | -24685.794% |
| Assisted 4 Living, Inc. | -199.71 Thousand USD | 22566.346% |
| BioCorRx Inc. | 5.56 Million USD | -705.601% |
| Bionik Laboratories Corp. | 1.98 Million USD | -2160.436% |
| Banyan Corp. | 3.6 Million USD | -1144.062% |
| Dental Patient Care America, Inc. | -1.99 Million USD | 2346.775% |
| Quantum Medical Transport, Inc. | 1065.27 USD | -4211788.817% |
| Empower Clinics Inc. | 2.29 Million USD | -1851.761% |
| First Choice Healthcare Solutions, Inc. | 23.22 Million USD | -93.148% |
| Selectis Health, Inc. | 35.76 Million USD | -25.463% |
| Ethema Health Corporation | 14.51 Million USD | -209.125% |
| HealthLynked Corp. | 1.72 Million USD | -2498.753% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 13.79 Million USD | -225.287% |
| JRSIS Health Care Corporation | 911.83 Thousand USD | -4820.637% |
| Comjoyful International Company | -28.32 Thousand USD | 158481.828% |
| Medical Facilities Corporation | 92.22 Million USD | 51.348% |
| MedSmart Group Inc. | 659.56 Thousand USD | -6702.705% |
| North America Frac Sand, Inc. | 265.41 Thousand USD | -16804.843% |
| Nova Leap Health Corp. | -686.52 Thousand USD | 6635.512% |
| Nexteligent Holdings, Inc. | 1.83 Million USD | -2340.792% |
| PAO Group, Inc. | 639.37 Thousand USD | -6917.476% |
| Primemd Inc. | 4.54 Million USD | -887.497% |
| Raffles Medical Group Ltd | -194.49 Million USD | 123.069% |
| Ryman Healthcare Limited | 1.51 Billion USD | 97.03% |
| Stem Cell Authority, Ltd. | 15.00 USD | -299119820.0% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | 1.24 Million USD | -3509.305% |
| Mycotopia Therapies, Inc. | 811.51 Thousand USD | -5428.903% |
| U.S. NeuroSurgical Holdings, Inc. | -381 Thousand USD | 11876.375% |
| Veltex Corporation | 2.17 Million USD | -1958.711% |
| World Financial Holding Group | 98.11 Thousand USD | -45630.931% |
| Xcelerate Inc. | 1.18 Million USD | -3693.483% |